Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $251.83 million. The enterprise value is $54.20 million.

Market Cap	251.83M
Enterprise Value	54.20M

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

NMRA has 161.95 million shares outstanding. The number of shares has increased by 24.37% in one year.

Current Share Class	161.95M
Shares Outstanding	161.95M
Shares Change (YoY)	+24.37%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	5.30%
Owned by Institutions (%)	42.46%
Float	86.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.33
P/TBV Ratio	1.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.54, with a Debt / Equity ratio of 0.11.

Current Ratio	10.54
Quick Ratio	10.28
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -89.37% and return on invested capital (ROIC) is -56.27%.

Return on Equity (ROE)	-89.37%
Return on Assets (ROA)	-52.63%
Return on Invested Capital (ROIC)	-56.27%
Return on Capital Employed (ROCE)	-130.53%
Revenue Per Employee	n/a
Profits Per Employee	-$2.29M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $183,000 in taxes.

Income Tax	183,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-86.07%
50-Day Moving Average	1.28
200-Day Moving Average	3.56
Relative Strength Index (RSI)	49.66
Average Volume (20 Days)	1,761,872

Short Selling Information

The latest short interest is 7.16 million, so 4.42% of the outstanding shares have been sold short.

Short Interest	7.16M
Short Previous Month	9.03M
Short % of Shares Out	4.42%
Short % of Float	8.32%
Short Ratio (days to cover)	3.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-264.54M
Pretax Income	-273.79M
Net Income	-252.09M
EBITDA	-264.06M
EBIT	-264.54M
Earnings Per Share (EPS)	-$1.57

Full Income Statement

Balance Sheet

The company has $217.59 million in cash and $19.96 million in debt, giving a net cash position of $197.63 million or $1.22 per share.

Cash & Cash Equivalents	217.59M
Total Debt	19.96M
Net Cash	197.63M
Net Cash Per Share	$1.22
Equity (Book Value)	182.88M
Book Value Per Share	1.13
Working Capital	201.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$195.68 million and capital expenditures $775,000, giving a free cash flow of -$194.90 million.

Operating Cash Flow	-195.68M
Capital Expenditures	775,000
Free Cash Flow	-194.90M
FCF Per Share	-$1.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.37%
Shareholder Yield	-24.37%
Earnings Yield	-100.10%
FCF Yield	-77.39%

Analyst Forecast

The average price target for NMRA is $7.14, which is 359.16% higher than the current price. The consensus rating is "Buy".

Price Target	$7.14
Price Target Difference	359.16%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-35.30%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1